295 related articles for article (PubMed ID: 9305329)
1. Altered systemic iron metabolism in Parkinson's disease.
Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin.
Fletcher LM; Halliday JW; Powell LW
J Gastroenterol Hepatol; 1999 Mar; 14(3):202-14. PubMed ID: 10197487
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
4. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
[TBL] [Abstract][Full Text] [Related]
5. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
Loeffler DA; Connor JR; Juneau PL; Snyder BS; Kanaley L; DeMaggio AJ; Nguyen H; Brickman CM; LeWitt PA
J Neurochem; 1995 Aug; 65(2):710-24. PubMed ID: 7616227
[TBL] [Abstract][Full Text] [Related]
6. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
McNamara L; MacPhail AP; Mandishona E; Bloom P; Paterson AC; Rouault TA; Gordeuk VR
J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
[TBL] [Abstract][Full Text] [Related]
7. Systemic iron metabolism and mortality from Parkinson's disease.
Marder K; Logroscino G; Tang MX; Graziano J; Cote L; Louis E; Alfaro B; Mejia H; Slavkovich V; Mayeux R
Neurology; 1998 Apr; 50(4):1138-40. PubMed ID: 9566409
[TBL] [Abstract][Full Text] [Related]
8. Effects of iron overload on chronic metabolic diseases.
Fernández-Real JM; Manco M
Lancet Diabetes Endocrinol; 2014 Jun; 2(6):513-26. PubMed ID: 24731656
[TBL] [Abstract][Full Text] [Related]
9. Serum transferrin receptors are decreased in the presence of iron overload.
Khumalo H; Gomo ZA; Moyo VM; Gordeuk VR; Saungweme T; Rouault TA; Gangaidzo IT
Clin Chem; 1998 Jan; 44(1):40-4. PubMed ID: 9550556
[TBL] [Abstract][Full Text] [Related]
10. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
[TBL] [Abstract][Full Text] [Related]
11. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
[TBL] [Abstract][Full Text] [Related]
12. The serum ferrokinetics in Parkinson's disease.
Chen WH; Shih PY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):581-4. PubMed ID: 1296037
[TBL] [Abstract][Full Text] [Related]
13. Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning.
He Y; Lee T; Leong SK
Free Radic Res; 1999 Aug; 31(2):103-12. PubMed ID: 10490239
[TBL] [Abstract][Full Text] [Related]
14. Decreased ferritin levels in brain in Parkinson's disease.
Dexter DT; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees AJ; Wells FR; Jenner P; Marsden CD
J Neurochem; 1990 Jul; 55(1):16-20. PubMed ID: 2355217
[TBL] [Abstract][Full Text] [Related]
15. Iron and iron-handling proteins in the brain after intracerebral hemorrhage.
Wu J; Hua Y; Keep RF; Nakamura T; Hoff JT; Xi G
Stroke; 2003 Dec; 34(12):2964-9. PubMed ID: 14615611
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
17. Increased iron levels and lipid peroxidation in a Mediterranean population of Spain.
Aranda N; Fernandez-Cao JC; Tous M; Arija V
Eur J Clin Invest; 2016 Jun; 46(6):520-6. PubMed ID: 26999720
[TBL] [Abstract][Full Text] [Related]
18. [Iron homeostasis and Parkinson's disease].
Faucheux BA; Hirsch EC
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():23-30. PubMed ID: 9827211
[No Abstract] [Full Text] [Related]
19. Transferrin receptors in the parkinsonian midbrain.
Morris CM; Candy JM; Omar S; Bloxham CA; Edwardson JA
Neuropathol Appl Neurobiol; 1994 Oct; 20(5):468-72. PubMed ID: 7845532
[TBL] [Abstract][Full Text] [Related]
20. The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
Faucheux BA; Hauw JJ; Agid Y; Hirsch EC
Brain Res; 1997 Feb; 749(1):170-4. PubMed ID: 9070646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
